In fact, 25 percent of cervical cancer diagnoses occur in women over the age of 65, and cervical cancers diagnosed in this ...

A parasitic worm may raise the risk of cervical cancer through several mechanisms, scientists have found, although HPV ...

A new study finds that Schistosoma haematobium infection, and its treatment, can activate cancer-related genes in the cervix, ...

During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

Metabolic barriers in the tumor microenvironment The tumor microenvironment — the complex environment that surrounds cancer cells — is often deprived of nutrients and oxygen, particularly in ...

MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with ... deals include its takeover of T-cell engager developer Harpoon ...

It's also surrounded by delicate nerves responsible for erections and the muscle that controls urine ... National Cancer Institute, high temperatures can damage or destroy cancer cells.

Tivdak is a first-in-class therapy that combines an antibody target at tissue factor – a protein expressed on cervical cancer cells – with a cell-killing drug called monomethyl auristatin E.

For late-stage and recurrent cervical cancer, a second chemotherapy may be added, e.g. paclitaxel. Tumor treating fields (TTFields) are electric fields that disrupt cellular processes critical for ...